The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Pneumocystis carinii Pneumonia Treated with Pyrimethamine and Sulfadiazine

[+] Article, Author, and Disclosure Information

Supported in part by grant 5T01AI00339, U.S. Public Health Service, Washington, D.C.

▸Requests for reprints should be adressed to James C. Guckian, M.D., Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Tex. 77550

Galveston, Texas

Ann Intern Med. 1971;75(4):505-509. doi:10.7326/0003-4819-75-4-505
Text Size: A A A

Pentamidine isethionate has been considered the only effective agent in the treatment of Pneumocystis carinii pneumonia. Its toxicity makes it less than the ideal drug. Pyrimethamine and sulfadiazine have been as effective as pentamidine in the treatment of P. carinii pneumonia in experimental animals. Results of prior reported treatment in human disease are reviewed. Three consecutive patients with biopsy-proved P. carinii pneumonia who were admitted to the medical service at the University of Texas Medical Branch Hospitals, Galveston, and treated with pyrimethamine and sulfadiazine are reported. Two patients were clinically cured and have had long-term follow-up. One patient showed clinical improvement with therapy but died of unknown causes shortly after completion of treatment; autopsy was not performed. The encouraging results obtained with the use of pyrimethamine and sulfadiazine indicate the need for further clinical trial with these readily available and relatively nontoxic antimicrobial agents.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.